Dexcom (DXCM) Amortizatization of Intangibles (2010 - 2021)
Dexcom's (DXCM) quarterly Amortizatization of Intangibles came in at $22.0 million in Q3 2021, up 1.38% year-on-year from $21.7 million in Q3 2020, and down 2.22% on a QoQ basis from $22.5 million in Q2 2021.
Dexcom (DXCM) Amortizatization of Intangibles (2010 - 2021) Analysis & Trends
Dexcom (DXCM) has 12 years of Amortizatization of Intangibles data on file, last reported at $22.0 million in Q3 2021.
- On a quarterly basis, Amortizatization of Intangibles rose 1.38% year-over-year to $22.0 million in Q3 2021; TTM through Sep 2021 was $88.4 million, a 36.84% increase from a year earlier, with the FY2019 full-year figure at $49.6 million, up 177.09% from the prior year.
- Amortizatization of Intangibles for Q3 2021 stood at $22.0 million, down from $22.5 million in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for DXCM reached as high as $22.5 million in Q2 2021 and fell as low as $100000.0 in Q1 2017.
- Historically, Amortizatization of Intangibles has averaged $10.2 million across 5 years, with a median of $6.6 million in 2018.
- Across the five-year window, Amortizatization of Intangibles soared 3600.0% in 2018 and grew 1.38% in 2021, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $3.7 million in 2017, then jumped by 78.38% to $6.6 million in 2018, then soared by 90.91% to $12.6 million in 2019, then surged by 72.22% to $21.7 million in 2020, then grew by 1.38% to $22.0 million in 2021.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $22.0 million in Q3 2021, $22.5 million in Q2 2021, and $22.2 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 22.00 Mn |
| Sep 30, 2021 | 22.00 Mn |
| Jun 30, 2021 | 22.50 Mn |
| Jun 30, 2021 | 22.50 Mn |
| Mar 31, 2021 | 22.20 Mn |
| Mar 31, 2021 | 22.20 Mn |
| Sep 30, 2020 | 21.70 Mn |
| Sep 30, 2020 | 21.70 Mn |
| Jun 30, 2020 | 17.60 Mn |
| Jun 30, 2020 | 17.60 Mn |
| Mar 31, 2020 | 12.70 Mn |
| Mar 31, 2020 | 12.70 Mn |
| Dec 31, 2019 | 12.60 Mn |
| Dec 31, 2019 | 12.60 Mn |
| Sep 30, 2019 | 3.50 Mn |
| Sep 30, 2019 | 3.50 Mn |
| Jun 30, 2019 | 3.40 Mn |
| Jun 30, 2019 | 3.40 Mn |
| Mar 31, 2019 | 12.20 Mn |
| Mar 31, 2019 | 12.20 Mn |